from breast cancer and its impact on survival. Thirteen female patients (range: 36-82 years, media 54.5 years) underwent RFA for the treatment of 21 liver metastases from breast cancer. The procedures were performed under US guidance using a RF 2000 or RF 3000 generator system and Le Veen monopolar needle electrodes. Follow up was carried-out by CT after 1,3,6,12 months. Technical success was 100%. No major or minor complications occurred at the end of the procedure. One month technique effectiveness was 95% (20 /21 lack of enhancement in the ablated tumor was observed). The mean overall survival after RFA was 10.9 months. Mean survival was calculated after the initial diagnosis of breast cancer and was 90.92 months. In conclusion, RFA appears to be a useful adjunct to systemic chemotherapy and/or ormonotherapy, in the loco-regional treatment of hepatic metastases from breast cancer. RFA may also be a less invasive alternative to surgery in the loco-regional treatment of liver metastases from breast cancer.
The role of percutaneous ultrasound guided radiofrequency ablation (RFA) in patients with breast cancer hepatic metastases
Laganà D;
2008-01-01
Abstract
from breast cancer and its impact on survival. Thirteen female patients (range: 36-82 years, media 54.5 years) underwent RFA for the treatment of 21 liver metastases from breast cancer. The procedures were performed under US guidance using a RF 2000 or RF 3000 generator system and Le Veen monopolar needle electrodes. Follow up was carried-out by CT after 1,3,6,12 months. Technical success was 100%. No major or minor complications occurred at the end of the procedure. One month technique effectiveness was 95% (20 /21 lack of enhancement in the ablated tumor was observed). The mean overall survival after RFA was 10.9 months. Mean survival was calculated after the initial diagnosis of breast cancer and was 90.92 months. In conclusion, RFA appears to be a useful adjunct to systemic chemotherapy and/or ormonotherapy, in the loco-regional treatment of hepatic metastases from breast cancer. RFA may also be a less invasive alternative to surgery in the loco-regional treatment of liver metastases from breast cancer.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.